{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:02:27Z","timestamp":1764331347218,"version":"build-2065373602"},"reference-count":36,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background\/Objectives: The long-term impact of the COVID-19 pandemic is not just limited to socioeconomic aspects; there are also important health issues to consider. Among these, one of the most important and obvious is long COVID. Despite a significant amount of scientific work having been published, this condition is still semi-unknown. The objective of this study was to collect useful information for the clarification of some epidemiological, clinical, and laboratory characteristics of this disease. Methods: This was a single-center study carried out at the Infectious Diseases Clinic of the hospital \u201cAUO delle Marche\u201d on all patients hospitalized for COVID-19 between November 2021 and March 2022. Results: From the data, it emerged that, following the resolution of the acute phase of SARS-CoV-2 infection, the majority of people experienced health problems that persisted for at least 6 months. The manifestations and outcomes affect different systems; therefore, long COVID, like COVID-19, has systemic involvement and the clinical manifestations may be residues of the damage caused by the disease during the acute phase, or new manifestations whose pathogenesis is still a matter of discussion. Conclusions: The persistence of inflammation and the dysregulation of the immune system represent some of the pathogenetic hypotheses. Inflammation could therefore represent one of the physiopathogenetic mechanisms of long COVID, and it is possible that it is responsible for the clinical symptoms that appear in the months following the resolution of the acute phase of the disease.<\/jats:p>","DOI":"10.3390\/diseases13100337","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:51:28Z","timestamp":1760428288000},"page":"337","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Severe Acute SARS-CoV-2 Infection and Long COVID: What Do We Know So Far? New Challenges in Diagnosis and Management"],"prefix":"10.3390","volume":"13","author":[{"given":"Sara","family":"Mazzanti","sequence":"first","affiliation":[{"name":"AUO delle Marche, Universit\u00e0 Politecnica delle Marche, Via Conca, 60100 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Barchiesi","sequence":"additional","affiliation":[{"name":"A.O. Ospedali Riuniti Marche Nord, Universit\u00e0 Politecnica delle Marche, Via Cesare Lombroso, 1, 61122 Pesaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pallotta","sequence":"additional","affiliation":[{"name":"AUO delle Marche, Universit\u00e0 Politecnica delle Marche, Via Conca, 60100 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilenia","family":"Luchetti","sequence":"additional","affiliation":[{"name":"AUO delle Marche, Universit\u00e0 Politecnica delle Marche, Via Conca, 60100 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Giacometti","sequence":"additional","affiliation":[{"name":"AUO delle Marche, Universit\u00e0 Politecnica delle Marche, Via Conca, 60100 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Brescini","sequence":"additional","affiliation":[{"name":"AUO delle Marche, Universit\u00e0 Politecnica delle Marche, Via Conca, 60100 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/d41586-022-01702-2","article-title":"How common is long COVID? Why studies give different answers","volume":"606","author":"Ledford","year":"2022","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"100122","DOI":"10.1016\/j.lanepe.2021.100122","article-title":"Post-COVID syndrome in non- hospitalised patients with COVID-19: A longitudinal prospective cohort study","volume":"6","author":"Augustin","year":"2021","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"113426","DOI":"10.1016\/j.socscimed.2020.113426","article-title":"How and why patients made Long Covid","volume":"268","author":"Callard","year":"2021","journal-title":"Soc. Sci. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent Symptoms in Patients After Acute COVID-19","volume":"324","author":"Bernabei","year":"2020","journal-title":"JAMA"},{"key":"ref_5","unstructured":"CDC (2022, July 19). Post-COVID Conditions. Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/long-covid\/about\/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcovid%2Flong-term-effects%2Findex.html."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"Soriano","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-de-las-Pe\u00f1as, C., Palacios-Ce\u00f1a, D., G\u00f3mez-Mayordomo, V., Cuadrado, M.L., and Florencio, L.L. (2021). Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18052621"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological sequelae of long-haul COVID","volume":"23","author":"Mehandru","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Shen, W.X., Luo, R.C., Wang, J.Q., and Chen, Z.S. (2021). Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19. Front. Public Health, 9.","DOI":"10.3389\/fpubh.2021.671788"},{"key":"ref_10","first-page":"22","article-title":"Long COVID-19 syndrome as a fourth phase of SARS-CoV-2 infection","volume":"30","author":"Staffolani","year":"2022","journal-title":"Infez. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/07853890.2022.2076901","article-title":"Pathophysiology and mechanism of long COVID: A comprehensive review","volume":"54","author":"Chalon","year":"2022","journal-title":"Ann. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Queiroz, M.A.F., Neves, P.F.M., Lima, S.S., Lopes, J.d.C., Torres, M.K.d.S., Vallinoto, I.M.V.C., de Brito, M.T.F.M., da Silva, A.L.S., Leite, M.d.M., and da Costa, F.P. (2022). Cytokine Profiles Associated with Acute COVID-19 and Long COVID-19 Syndrome. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.922422"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"100899","DOI":"10.1016\/j.eclinm.2021.100899","article-title":"Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis","volume":"36","author":"Iqbal","year":"2021","journal-title":"eClinicalMedicine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6175964","DOI":"10.1155\/2020\/6175964","article-title":"Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies","volume":"2020","author":"Ojo","year":"2020","journal-title":"Pulm. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S2213-2600(20)30407-0","article-title":"Beyond the clot: Perfusion imaging of the pulmonary vasculature after COVID-19","volume":"9","author":"Dhawan","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/imr.12977","article-title":"COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts","volume":"302","author":"John","year":"2021","journal-title":"Immunol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Garcia-Revilla, J., Deierborg, T., Venero, J.L., and Boza-Serrano, A. (2020). Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.02069"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Bulfamante, G.P., Perrucci, G.L., Falleni, M., Sommariva, E., Tosi, D., Martinelli, D., Songia, P., Poggio, P., Carugo, S., and Pompilio, G. (2020). Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement. Biomedicines, 8.","DOI":"10.1101\/2020.08.24.20170175"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.7861\/clinmed.2020-0896","article-title":"Autonomic dysfunction in \u201clong COVID\u201d: Rationale, physiology and management strategies","volume":"21","author":"Dani","year":"2021","journal-title":"Clin. Med. Lond. Engl."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","article-title":"More than 50 Long-term effects of COVID-19: A systematic review and meta-analysis","volume":"11","author":"Perelman","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1111\/jdv.17803","article-title":"Is there a POST-COVID dermatological syndrome? The integrated dermato-infectious disease experience of a single centre","volume":"36","author":"Diotallevi","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","article-title":"6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/jama.2024.24184","article-title":"2024 Update of the RECOV-ER-Adult Long COVID Research Index","volume":"333","author":"Linda","year":"2025","journal-title":"JAMA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e14547","DOI":"10.1111\/dth.14547","article-title":"Telogen effluvium related to post severe Sars-CoV-2 infection: Clinical aspects and our management experience","volume":"34","author":"Rizzetto","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/medicina57050418","article-title":"Long COVID and Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology","volume":"57","author":"Wong","year":"2021","journal-title":"Medicina"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/hep.31480","article-title":"Abnormal Liver Function Tests in Patients with COVID-19: Relevance and Potential Pathogenesis","volume":"72","author":"Bertolini","year":"2020","journal-title":"Hepatology"},{"key":"ref_28","first-page":"834","article-title":"Hematological findings and complications of COVID-19","volume":"2020","author":"Terpos","year":"2023","journal-title":"Am. J. Hematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s42255-021-00407-6","article-title":"Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection","volume":"3","author":"Montefusco","year":"2021","journal-title":"Nat. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.17749\/2313-7347.141","article-title":"Laboratory monitoring of COVID-19 patients and importance of coagulopathy markers","volume":"14","author":"Khizroeva","year":"2020","journal-title":"Obstet. Gynecol. Reprod."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3390\/v16071060","article-title":"Exproring the complexities of Long COVID","volume":"16","author":"Jackson","year":"2024","journal-title":"Viruses"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/17476348.2024.2438104","article-title":"Long COVID: A consequence of chronic post-infectious inflammation!","volume":"18","author":"Joseph","year":"2024","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_33","first-page":"156","article-title":"Long COVID: Emerging patophysiological mechanism","volume":"116","author":"Michael","year":"2025","journal-title":"Minerva Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaci.2024.12.1074","article-title":"Long COVID: Pathophysiology, current concepts and future directions","volume":"155","author":"Chrysanthu","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SPC.0000000000000755","article-title":"Long COVID update: Respiratory sequelae and symptoms","volume":"19","author":"Muhammad","year":"2025","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_36","first-page":"30","article-title":"Lond COVID or Post-Acute Sequelae od Sars-CoV-2 Infection (PASC) and the Urgent Need to Identify Diagnostic Biomarkers and Risk Factors","volume":"18","author":"Dinah","year":"2024","journal-title":"Med. Sci. Monit."}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/10\/337\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T08:28:23Z","timestamp":1760430503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/10\/337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["diseases13100337"],"URL":"https:\/\/doi.org\/10.3390\/diseases13100337","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]}}}